Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis

被引:0
作者
Z. J. Lee
S. L. Chia
G. Tan
K. C. Soo
C. C. M. Teo
机构
[1] National Cancer Center,Division of Surgical Oncology
来源
Annals of Surgical Oncology | 2018年 / 25卷
关键词
Hyperthermic Intraperitoneal Chemotherapy (HIPEC); Colorectal Peritoneal Carcinomatosis; Cytoreductive Surgery; National Cancer Centre Singapore (NCCS); Palliative Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2340 / 2346
页数:6
相关论文
共 34 条
  • [1] Sugarbaker PH(2014)Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer World J Gastroenterol. 20 9286-9291
  • [2] Sugarbaker PH(2005)Surgical management of carcinomatosis from colorectal cancer Clin Colon Rectal Surg. 18 190-203
  • [3] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasm with Pseudomyxoma peritonei syndrome Lancet Oncol. 1 69-76
  • [4] Thomassen I(2013)Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin Dis Colon Rectum. 56 1373-1380
  • [5] van Gestel YR(2016)Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis Ann Surg. 263 1102-1111
  • [6] Lemmens VE(2010)Peritoneal-based malignancies and their treatment (review) Ann Acad Med Singapore. 39 54-57
  • [7] de Hingh IH(2010)Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center Ann Acad Med Singapore. 39 54-57
  • [8] Kwakman R(1931)Implantation peritoneal carcinomatosis of ovarian origin Am J Pathol. 7 39-353
  • [9] Schrama AM(2008)Cost effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer Value Health. 11 347-408
  • [10] van Olmen JP(2011)Morbidity and morality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. National Cancer Institute, Mexico City, Mexico Oncology. 2011 526384-916